- McKesson Corporation (NYSE: MCK), headquartered in Irving, Texas, is a leading healthcare services company specializing in pharmaceutical distribution and healthcare supply chain management, with a focus on oncology and biopharma services.
- In April 2026, McKesson sold a 13% minority stake in its Medical-Surgical Solutions division to Apollo Funds for $1.25 billion, as part of a strategy to prepare for an IPO of the division in 2027, while also acquiring a 70% stake in CORE Ventures for $2.49 billion to enhance its physician network in Florida.
- Key partnerships include the recent agreement with Apollo Funds and the acquisition of CORE Ventures, which supports over 250 physicians across nearly 100 locations, indicating a strong focus on expanding healthcare services.
- McKesson's ideal buyers are healthcare providers and organizations seeking efficient supply chain solutions and enhanced access to oncology and biopharma services, addressing the growing demand for specialized healthcare delivery amid evolving market conditions.
McKesson's workforce is organized into 19 departments, with Operations leading at 4,595 employees, followed by Sales with 2,217 and Information Technology at 2,368. This distribution indicates a strong emphasis on operational efficiency and technology support, essential for a health care wholesaler. The balanced presence of departments such as Finance and Community and Social Services, with 1,162 and 1,350 employees respectively, underscores the company's commitment to both fiscal responsibility and community engagement.
The company's workforce is geographically diverse, with the largest concentration in San Francisco, CA, housing 2,643 employees, followed by Saint Paul, MN, with 1,540. Other significant locations include Alpharetta, GA, and Irving, TX, with headcounts of 812 and 693, respectively. The high number of employees categorized under 'Other' (9,718) suggests a distributed workforce model, allowing for flexibility and regional responsiveness in various markets.
